S, O., S, J., A, C., S, R., Y, O., SA, M., . . . YK, B. (2025). PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide. Research square. https://doi.org/10.21203/rs.3.rs-5936706/v1
Chicago Style (17th ed.) CitationS, Onishi, et al. "PRMT5 Inhibition Sensitizes Glioblastoma Tumor Models to Temozolomide." Research Square 2025. https://doi.org/10.21203/rs.3.rs-5936706/v1.
MLA (9th ed.) CitationS, Onishi, et al. "PRMT5 Inhibition Sensitizes Glioblastoma Tumor Models to Temozolomide." Research Square, 2025, https://doi.org/10.21203/rs.3.rs-5936706/v1.
Warning: These citations may not always be 100% accurate.